| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.4 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |